US EditionSynchron Debuts Native Thought-Controlled iPad With Apple's BCI HID Protocol
UNITED STATES, AUG 4 – Synchron's Stentrode implant enables a person with ALS to control an iPad using Apple's Brain-Computer Interface protocol, with 10 patients implanted under FDA approval for clinical trials.
- Synchron showcased a public breakthrough in which Mark Jackson uses their Stentrode brain implant to operate an iPad solely through thought.
- This event comes after Mark received his Stentrode implant in 2023 and follows Apple's introduction in May of a new protocol that allows brain implants to directly interact with Apple devices as input controls.
- Mark, who has ALS, operates his iPad by controlling its interface, launching applications, and writing messages solely through thought, without needing to use his hands, voice, or eyes, utilizing Apple’s Switch Control accessibility feature in combination with the implant.
- Dr. Tom Oxley, CEO, described Mark's achievement as a significant advancement that offers a preview of how brain-computer communication could evolve, with thought-based control becoming a common means of interacting with technology.
- Synchron says this integration marks a critical step toward making BCI technology practical and scalable beyond clinical trials, moving it into everyday use with broader Apple support expected.
Insights by Ground AI
Does this summary seem wrong?
22 Articles
22 Articles
Coverage Details
Total News Sources22
Leaning Left1Leaning Right0Center5Last UpdatedBias Distribution83% Center
Bias Distribution
- 83% of the sources are Center
83% Center
L 17%
C 83%
Factuality
To view factuality data please Upgrade to Premium
